What is Winshine Science Co Operating Cash Flow per Share?
Winshine Science Co's operating cash flow per share for the
six
months ended in Dec. 2023 was HK$1.30.
Winshine Science Co's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.28.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Winshine Science Co was -78.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Winshine Science Co's Operating Cash Flow per Share or its related term are showing as below:
During the past 13 years, Winshine Science Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 50.60% per year. The lowest was -43.90% per year. And the median was -1.35% per year.
HKSE:00209's 3-Year OCF Growth Rate is not ranked *
in the Travel & Leisure industry.
Industry Median: 17.7 * Ranked among companies with meaningful 3-Year OCF Growth Rate only.
Winshine Science Co Operating Cash Flow per Share Historical Data
The historical data trend for Winshine Science Co's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Winshine Science Co Operating Cash Flow per Share Chart
Competitive Comparison of Winshine Science Co's Operating Cash Flow per Share
For the Leisure subindustry, Winshine Science Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Winshine Science Co's Price-to-Operating-Cash-Flow Distribution in the Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Winshine Science Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Winshine Science Co's Price-to-Operating-Cash-Flow falls into.
Winshine Science Co Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Winshine Science Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.28
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Winshine Science Co Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Winshine Science Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Winshine Science Co (HKSE:00209) Business Description
Winshine Science Co Ltd is an investment holding company. The company's segment includes Securities investments, Toys, and Medical & health. It generates maximum revenue from the Toys segment. The toys segment derives its revenue from manufacturing for the sale of toys. The securities investments segment derives its profits or losses from dividends received from, and other gains or losses from, equity securities investments. The medical and health segment is under the development stage in which research and development expenses for medical and health technology development have been incurred. Its geographical segments are Hong Kong, China, the United States, Europe, and Korea, of which the majority of its revenue comes from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00209 has been successfully added to your 